First-episode psychosis: Psychopathology, quality of life, and functional outcome

Schizophrenia Bulletin

Volumn 31, Issue 3, 2005, Pages 650-671

  Malla, Ashok ^a   Payne, Jennifer ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

First episode; Functional; Outcome; Psychosis

Indexed keywords

BEHAVIOR; COGNITION; COMMUNITY; DEPRESSION; FUNCTIONAL ASSESSMENT; HUMAN; LONGITUDINAL STUDY; MEASUREMENT; MEDICAL LITERATURE; MENTAL DISEASE; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PSYCHOBIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOSIS; QUALITY OF LIFE; REVIEW; SCHIZOPHRENIA; SOCIAL ASPECT; SUBSTANCE ABUSE; SYMPTOM;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; AGE OF ONSET; COGNITION; COMORBIDITY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; PSYCHOTIC DISORDERS; QUALITY OF LIFE; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 24344461402     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/schbul/sbi031     Document Type: Review

References (218)

1. Ram R, Bromet EJ, Eaton WW, Pato C, Schwartz JE. The natural course of schizophrenia: a review of first-admission studies. Schizophrenia Bull 1992;18(2):185-207.
2. Schwartz JE, Fennig S, Tanenberg-Karant M, et al. Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis. Arch Gen Psychiat 2000;57(6):593-600.
3. Mason P, Harrison G, Croudace T, Glazebrook C, Medley I. The predictive validity of a diagnosis of schizophrenia: a report from the International Study of Schizophrenia (ISoS) coordinated by the World Health Organization and the Department of Psychiatry, University of Nottingham. Brit J Psychiat 1997;170:321-327.
4. Chen YR, Swann AC, Burt DB. Stability of diagnosis in schizophrenia. Am J Psychiat 1996;153(5):682-686.
5. McGlashan TH. Testing four diagnostic systems for schizophrenia. Arch Gen Psychiat 1984;41(2):141-144.
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd rev. ed. Washington, DC: American Psychiatric Press Inc.; 1987.
7. Schimmelmann B, Conus P, Edwards J, McGorry P, Lambert M. Diagnostic stability 18-months after a first diagnosis of psychosis. J Clin Psychiat 2005;in press.
8. Fennig S, Kovasznay B, Rich C, et al. Six-month stability of psychiatric diagnoses in first-admission patients with psychosis. Am J Psychiat 1994;151(8):1200-1208.
9. Kampman O, Kiviniemi P, Koivisto E, et al. Patient characteristics and diagnostic discrepancy in first-episode psychosis. Compr Psychiat 2004;45(3):213-218.
10. Gelber EI, Kohler CG, Bilker WB, et al. Symptom and demographic profiles in first-episode schizophrenia. Schizophr Res 2004;67(2-3):185-194.
11. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust NZ J Psychiat 2005;39(1-2):1-30.
12. National Institute for Clinical Excellence. Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. London: National Institute for Clinical Excellence; 2002.
13. Liddle PF. The symptoms of chronic schizophrenia: a re-examination of the positive-negative dichotomy. Brit J Psychiat 1987;151:145-151.
14. Malla AK, Norman RM, Williamson P, Cortese L, Diaz F. Three syndrome concept of schizophrenia: a factor analytic study. Schizophr Res 1993;10(2):143-150.
15. Andreasen NC, Arndt S, Alliger R, Miller D, Flaum M. Symptoms of schizophrenia: methods, meanings, and mechanisms. Arch Gen Psychiat 1995;52(5):341-351.
16. Johnstone EC, Frith CD. Validation of three dimensions of schizophrenic symptoms in a large unselected sample of patients. Psychol Med 1996;26(4):669-679.
17. Peralta V, Cuesta MJ, de Leon J. An empirical analysis of latent structures underlying schizophrenic symptoms: a four-syndrome model. Biol Psychiat 1994;36(11):726-736.
18. Lenzen weger MF, Dworkin RH. The dimensions of schizophrenia phenomenology: not one or two, at least three, perhaps four. Brit J Psychiat 1996;168(4):432-440.
19. Mellers JD, Sham P, Jones PB, Toone BK, Murray RM. A factor analytic study of symptoms in acute schizophrenia. Acta Psychiat Scand 1996;93(2):92-98.
20. Lindenmayer JP, Bernstein-Hyman R, Grochowski S, Bark N. Psychopathology of schizophrenia: initial validation of a 5-factor model. Psychopathology 1995;28(1):22-31.
21. McGorry PD, Bell RC, Dudgeon PL, Jackson HJ. The dimensional structure of first episode psychosis: an exploratory factor analysis. Psychol Med 1998;28(4):935-947.
22. Eaton WW, Thara R, Federman B, Melton B, Liang KY. Structure and course of positive and negative symptoms in schizophrenia. Arch Gen Psychiat 1995;52(2):127-134.
23. Arndt S, Andreasen NC, Flaum M, Miller D, Nopoulos P. A longitudinal study of symptom dimensions in schizophrenia: prediction and patterns of change. Arch Gen Psychiat 1995;52(5):352-360.
24. Fenton WS, McGlashan TH. Natural history of schizophrenia subtypes. I. longitudinal study of paranoid, hebephrenic, and undifferentiated schizophrenia. Arch Gen Psychiat 1991;48(11):969-977.
25. McGlashan TH, Fenton WS. Subtype progression and pathophysiologic deterioration in early schizophrenia. Schizophrenia Bull 1993;19(1):71-84.
26. Ventura J, Nuechterlein KH, Subotnik K, Gilbert E. Symptom dimensions in recent-onset schizophrenia: the 24-item expanded BPRS. Paper presented at the International Congress on Schizophrenia Research, Hot Springs, VA, April 10, 1995.
27. Van der Does AJ, Linszen DH, Dingemans PM, Nugter MA, Scholte WF. A dimensional and categorical approach to the symptomatology of recent-onset schizophrenia. J Nerv Ment Dis 1993;181(12):744-749.
28. Vazquez-Barquero JL, Lastra I, Cuesta Nunez MJ, Herrera Castanedo S, Dunn G. Patterns of positive and negative symptoms in first episode schizophrenia. Brit J Psychiat 1996;168(6):693-701.
29. Gureje O, Aderibigbe YA, Obikoya O. Three syndromes in schizophrenia: validity in young patients with recent onset of illness. Psychol Med 1995;25(4):715-725.
30. Van Os J, Fahy TA, Jones P, et al. Psychopathological syndromes in the functional psychoses: associations with course and outcome. Psychol Med 1996;26(1):161-176.
31. Cuesta MJ, Peralta V, Gil P, Artamendi M. Psychopathological dimensions in first-episode psychoses: from the trunk to the branches and leaves. Eur Arch Psy Clin N 2003;253(2):73-79.
32. Liddle PF, Friston KJ, Frith CD, Hirsch SR, Jones T, Frackowiak RS. Patterns of cerebral blood flow in schizophrenia. Brit J Psychiat 1992;160:179-186.
33. Shtasel DL, Gur RE, Gallacher F, Heimberg C, Cannon T, Gur RC. Phenomenology and functioning in first-episode schizophrenia. Schizophrenia Bull 1992;18(3):449-462.
34. Johns LC, Hemsley D, Kuipers E. A comparison of auditory hallucinations in a psychiatric and non-psychiatric group. Brit J Clin Psychol 2002;41(1):81-86.
35. van Os J, Hanssen M, Bijl RV, Ravelli A. Strauss (1969) revisited: a psychosis continuum in the general population? Schizophr Res 2000;45(1-2):11-20.
36. van Os J. Is there a continuum of psychotic experiences in the general population? Epidemiol Psichiat Soc 2003;12(4):242-252.
37. Poulton R, Caspi A, Moffitt TE, Cannon M, Murray R, Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch Gen Psichiat 2000;57(11):1053-1058.
38. van Os J, Jones PB. Neuroticism as a risk factor for schizophrenia. Psychol Med 2001;31(6):1129-1134.
39. Verdoux H, Maurice-Tison S, Gay B, Van Os J, Salamon R, Bourgeois ML. A survey of delusional ideation in primary-care patients. Psychol Med 1998;28(1):127-134.
40. McGue M, Gottesman I, Rao DC. Resolving genetic models for the transmission of schizophrenia. Genet Epidemiol 1985;2(1):99-110.
41. Zubin J, Spring B. Vulnerability - a new view of schizophrenia. J Abnorm Psychol 1977;86(2):103-126.
42. Norman RM, Malla AK. Stressful life events and schizophrenia: I. a review of the research. Brit J Psychiat 1993;162:161-166.
43. Nuechterlein KH, Dawson ME, Gitlin M, et al. Developmental processes in schizophrenic disorders: longitudinal studies of vulnerability and stress. Schizophrenia Bull 1992;18(3):387-425.
44. Browne S, Roe M, Lane A, et al. Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiat Scand 1996;94(2):118-124.
45. Galletly CA, Clark CR, McFarlane AC, Weber DL. Relationships between changes in symptom ratings, neurophysiological test performance and quality of life in schizophrenic patients treated with clozapine. Psychiat Res 1997;72(3):161-166.
46. Ho BC, Nopoulos P, Flaum M, Arndt S, Andreasen NC. Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. Am J Psychiat 1998;155(9):1196-1201.
47. Brown KW, White T. Syndromes of chronic schizophrenia and some clinical correlates. Brit J Psychiat 1992;161:317-322.
48. Norman RM, Malla AK, Morrison-Stewart SL, et al. Neuropsychological correlates of syndromes in schizophrenia. Brit J Psychiat 1997;170:134-139.
49. Liddle PF. Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychol Med 1987;17(1):49-57.
50. Liddle PF, Morris DL. Schizophrenic syndromes and frontal lobe performance. Brit J Psychiat 1991;158:340-345.
51. Szymanski SR, Cannon TD, Gallacher F, Erwin RJ, Gur RE. Course of treatment response in first-episode and chronic schizophrenia. Am J Psychiat 1996;153(4):519-525.
52. Tandon R, Jibson MD, Taylor SF, DeQuardo JR. Conceptual models of the relationship between positive and negative symptoms. In: Shriqui C, Nasrallah HA, eds. Contemporary Issues in the Treatment of Schizophrenia. Washington, DC: American Psychiatric Press; 1995;109-124.
53. Tollefson GD, Sanger TM. Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine. Am J Psychiat 1997;154(4):466-474.
54. Carpenter WT, Jr., Heinrichs DW, Wagman AM. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiat 1988;145(5):578-583.
55. Kirkpatrick B, Buchanan RW, Ross DE, Carpenter WT, Jr. A separate disease within the syndrome of schizophrenia. Arch Gen Psychiat 2001;58(2):165-171.
56. Mayerhoff DI, Loebel AD, Alvir JM, et al. The deficit state in first-episode schizophrenia. Am J Psychiat 1994;151(10):1417-1422.
57. Malla AK, Takhar JJ, Norman RM, et al. Negative symptoms in first episode non-affective psychosis. Acta Psychiat Scand 2002;105(6):431-439.
58. Malla AK, Norman RM, Takhar J, et al. Can patients at risk for persistent negative symptoms be identified during their first episode of psychosis? J Nerv Ment Dis 2004;192(7):455-463.
59. Edwards J, McGorry PD, Waddell FM, Harrigan SM. Enduring negative symptoms in first-episode psychosis: comparison of six methods using follow-up data. Schizophr Res 1999;40(2):147-158.
60. Kirkpatrick B, Ram R, Bromet E. The deficit syndrome in the Suffolk County Mental Health Project. Schizophr Res 1996;22(2):119-126.
61. Bleuler E. Dementia Praecox or the Group of Schizophrenia. New York: International Universities Press; 1950 (1911).
62. Cameron D. Early schizophrenia. Am J Psychiat 1938;95:567-578.
63. Stein W. The sense of becoming psychotic. Psychiatr 1967;30:262-275.
64. Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophrenia Bull 1996;22(2):353-370.
65. Yung AR, McGorry PD. The initial prodrome in psychosis: descriptive and qualitative aspects. Aust NZ J Psychiat 1996;30(5):587-599.
66. Parnas J. From predisposition to psychosis: progression of symptoms in schizophrenia. Acta Psychiat Scand Suppl 1999;395:20-29.
67. Moller P, Husby R. The initial prodrome in schizophrenia: searching for naturalistic core dimensions of experience and behavior. Schizophrenia Bull 2000;26(1):217-232.
68. an der Heiden W, Hafner H. The epidemiology of onset and course of schizophrenia. Eur Arch Psy Clin N 2000;250(6):292-303.
69. Gourzis P, Katrivanou A, Beratis S. Symptomatology of the initial prodromal phase in schizophrenia. Schizophrenia Bull 2002;28(3):415-429.
70. Tan HY, Ang YG. First-episode psychosis in the military: a comparative study of prodromal symptoms. Aust NZ J Psychiat 2001;35(4):512-519.
71. Norman RM, Scholten DJ, Malla AK, Ballageer T. Early signs in schizophrenia spectrum disorders. J Nerv Ment Dis 2005;193(1):17-23.
72. McGlashan TH, Miller TJ, Woods SW. Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit and risk. Schizophrenia Bull 2001;27(4):563-570.
73. Yung AR, McGorry PD. Is pre-psychotic intervention realistic in schizophrenia and related disorders? Aust NZ J Psychiat 1997;31(6):799-805.
74. Klosterkotter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiat 2001;58(2):158-164.
75. Huber G, Gross G, Schuttler R, Linz M. Longitudinal studies of schizophrenic patients. Schizophrenia Bull 1980;6(4):592-605.
76. Klosterkotter J, Ebel H, Schultze-Lutter F, Steinmeyer EM. Diagnostic validity of basic symptoms. Eur Arch Psy Clin N 1996;246(3):147-154.
77. Hafner H, Riecher-Rossler A, Hambrecht M. IRAOS: An instrument for the assessment of onset and early course of schizophrenia. Schizophr Res 1992;6:209-223.
78. Miller TJ, McGlashan TH, Woods SW, et al. Symptom assessment in schizophrenic prodromal states. Psychiat Quart 1999;70(4):273-287.
79. Phillips LJ, Yung AR, Yuen HP, Pantelis C, McGorry PD. Prediction and prevention of transition to psychosis in young people at incipient risk for schizophrenia. Am J Med Genet 2002;114(8):929-937.
80. Yung AR, Phillips LJ, Yuen HP, et al. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res 2003;60(1):21-32.
81. Miller TJ, McGlashan TH, Rosen JL, et al. Prodromal assessment using the SIPS and SOPS. Schizophr Res 2004;70(suppl 1):74.
82. Hawkins KA, McGlashan TH, Quinlan D, et al. Factorial structure of the Scale of Prodromal Symptoms. Schizophr Res 2004;68(2-3):339-347.
83. Vaglum P. Earlier detection and intervention in schizophrenia: unsolved questions. Schizophrenia Bull 1996;22(2):347-351.
84. Hafner H. Onset and early course as determinants of the further course of schizophrenia. Acta Psychiat Scand Suppl 2000;407:44-48.
85. McGlashan TH, Miller TJ, Woods SW, Hoffmam RE, Davidson L. A scale for the assessment of prodromal symptoms and states. In: Miller TJ, Mednick SA, McGlashan TH, Libiger J, Johannessen JA, eds. Early Intervention in Psychotic Disorders. Dordrecht: Kluwer Academic Publishers; 2001:135-150.
86. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiat 1987;44(7):660-669.
87. Murray RM. Neurodevelopmental schizophrenia: the rediscovery of dementia praecox. Brit J Psychiat Suppl 1994;25:6-12.
88. Olin SC, Mednick SA. Risk factors of psychosis: identifying vulnerable populations premorbidly. Schizophrenia Bull 1996;22(2):223-240.
89. Watt NF, Lubensky AW. Childhood roots of schizophrenia. J Consult Clin Psych 1976;44(3):363-375.
90. Addington D, Addington JM, Ens I. Mentally retarded patients on general hospital psychiatric units. Can J Psychiat 1993;38(2):134-136.
91. Gupta S, Rajaprabhakaran R, Arndt S, Flaum M, Andreasen NC. Premorbid adjustment as a predictor of phenomenological and neurobiological indices in schizophrenia. Schizophr Res 1995;16(3):189-197.
92. Keefe RS, Mohs RC, Losonczy MF, et al. Premorbid sociosexual functioning and long-term outcome in schizophrenia. Am J Psychiat 1989;146(2):206-211.
93. Kelley ME, Gilbertson M, Mouton A, van Kammen DP. Deterioration in premorbid functioning in schizophrenia: a developmental model of negative symptoms in drug-free patients. Am J Psychiat 1992;149(11):1543-1548.
94. Addington J, van Mastrigt S, Addington D. Patterns of premorbid functioning in first-episode psychosis: initial presentation. Schizophr Res 2003;62(1-2):23-30.
95. Larsen TK, McGlashan TH, Johannessen JO, Vibe-Hansen L. First-episode schizophrenia: II. premorbid patterns by gender. Schizophrenia Bull 1996;22(2):257-269.
96. Rabinowitz J, De Smedt G, Harvey PD, Davidson M. Relationship between premorbid functioning and symptom severity as assessed at first episode of psychosis. Am J Psychiat 2002;159(12):2021-2026.
97. Haas GL, Sweeney JA. Premorbid and onset features of first-episode schizophrenia. Schizophrenia Bull 1992;18(3):373-386.
98. Cannon-Spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophrenia Bull 1982;8(3):470-484.
99. Norman R, Malla A, Manchanda R, Townsend L. Premorbid adjustment in first episode schizophrenia spectrum disorders: a comparison of social and academic domains. Acta Psychiat Scand 2005;in press.
100. Cuesta MJ, Gil P, Artamendi M, Serrano JF, Peralta V. Premorbid personality and psychopathological dimensions in first-episode psychosis. Schizophr Res 2002;58(2-3):273-280.
101. Tyrer P. Personality Disorders: Diagnosis, Management and Course. Tyrer P, ed. London: Wright, Butterworth Scientific; 1988.
102. Tyrer P, Johnson T. Establishing the severity of personality disorder. Am J Psychiat 1996;153(12):1593-1597.
103. Humphreys MS, Johnstone EC, MacMillan JF, Taylor PJ. Dangerous behaviour preceding first admissions for schizophrenia. Brit J Psychiat 1992;161:501-505.
104. Steinert T, Wiebe C, Gebhardt RP. Aggressive behavior against self and others among first-admission patients with schizophrenia. Psychiatr Serv 1999;50(1):85-90.
105. Foley SR, Kelly BD, Clarke M, et al. Incidence and clinical correlates of aggression and violence at presentation in patients with first episode psychosis. Schizophr Res 2005;72(2-3):161-168.
106. Payne JR, Malla A, Norman R, Windel D, Brown N. Status of first episode psychosis patients presenting for routine care in a defined catchment area. Schizophrenia Bull 2005;31:235.
107. Brown S. Excess mortality of schizophrenia: a meta-analysis. Brit J Psychiat 1997;171:502-508.
108. Verdoux H, Liraud F, Gonzales B, Assens F, Abalan F, van Os J. Suicidality and substance misuse in first-admitted subjects with psychotic disorder. Acta Psychiat Scand 1999;100(5):389-395.
109. Addington J, Van Mastrigt S, Addington D. Duration of untreated psychosis: impact on 2-year outcome. Psychol Med 2004;34(2):277-284.
110. Nordentoft M, Jeppesen P, Abel M, et al. OPUS study: suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis, one-year follow-up of a randomised controlled trial. Brit J Psychiat Suppl 2002;43:S98-S106.
111. Verdoux H, Liraud F, Gonzales B, Assens F, Abalan F, van Os J. Predictors and outcome characteristics associated with suicidal behaviour in early psychosis: a two-year follow-up of first-admitted subjects. Acta Psychiat Scand 2001;103(5):347-354.
112. Preston NJ, Orr KG, Date R, Nolan L, Castle DJ. Gender differences in premorbid adjustment of patients with first episode psychosis. Schizophr Res 2002;55(3):285-290.
113. Castle DJ, Wessely S, Murray RM. Sex and schizophrenia: effects of diagnostic stringency, and associations with premorbid variables. Brit J Psychiat 1993;162:658-664.
114. Addington J, Young J, Addington D. Social outcome in early psychosis. Psychol Med 2003;33(6):1119-1124.
115. Malla A, Norman R, McLean T, Scholten D, Townsend L. A Canadian programme for early intervention in non-affective psychotic disorders. Aust NZ J Psychiat 2003;37(4):407-413.
116. de Haan L, Linszen DH, Lenior ME, de Win ED, Gorsira R. Duration of untreated psychosis and outcome of schizophrenia: delay in intensive psychosocial treatment versus delay in treatment with antipsychotic medication. Schizophrenia Bull 2003;29(2):341-348.
117. Dworkin RH. Patterns of sex differences in negative symptoms and social functioning consistent with separate dimensions of schizophrenic psychopathology. Am J Psychiat 1990;147(3):347-349.
118. Castle DJ, Murray RM. The neurodevelopmental basis of sex differences in schizophrenia. Psychol Med 1991;21(3):565-575.
119. Strous RD, Alvir JM, Robinson D, et al. Premorbid functioning in schizophrenia: relation to baseline symptoms, treatment response, and medication side effects. Schizophrenia Bull 2004;30(2):265-278.
120. Cawthron P, James A, Dell J, Seagroatt V. Adolescent onset psychosis: a clinical and outcome study. J Child Psychol Psyc 1994;35(7):1321-1332.
121. Gillberg IC, Hellgren L, Gillberg C. Psychotic disorders diagnosed in adolescence: outcome at age 30 years. J Child Psychol Psyc 1993;34(7):1173-1185.
122. Maziade M, Bouchard S, Gingras N, et al. Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. II: postnegative distinction and childhood predictors of adult outcome. Brit J Psychiat 1996;169(3):371-378.
123. Hollis C. Adult outcomes of child- and adolescent-onset schizophrenia: diagnostic stability and predictive validity. Am J Psychiat 2000;157(10):1652- 1659.
124. Werry JS. Child and adolescent (early onset) schizophrenia: a review in light of DSM-III-R. J Autism Dev Disord 1992;22(4):601-624.
125. Russell AT, Bott L, Sammons C. The phenomenology of schizophrenia occurring in childhood. J Am Acad Child Psy 1989;28(3):399-407.
126. Werry JS, McClellan JM, Chard L. Childhood and adolescent schizophrenic, bipolar, and schizoaffective disorders: a clinical and outcome study. J Am Acad Child Psy 1991;30(3):457-465.
127. Joyce PR. Age of onset in bipolar affective disorder and misdiagnosis as schizophrenia. Psychol Med 1984;14(1):145-149.
128. Carlson GA. Child and adolescent mania - diagnostic considerations. J Child Psychol Psyc 1990;31(3):331-341.
129. Thakur A, Jagadheesan K, Sinha VK. Psychopathological dimensions in childhood and adolescent psychoses: a confirmatory factor analytical study. Psychopathology 2003;36(4):190-194.
130. Ballageer T, Malla AK, Manchanda R, Takhar J, Haricharan R. Adolescent and adult onset of psychosis. J Am Acad Child Psy 2005;in press.
131. Gonzalez-Pinto Avan Os J, Peralta V, et al. The role of age in the development of Schneiderian symptoms in patients with a first psychotic episode. Acta Psychiat Scand 2004;109(4):264-268.
132. Escher S, Romme M, Buiks A, Delespaul P, Van Os J. Independent course of childhood auditory hallucinations: a sequential 3-year follow-up study. Brit J Psychiat Suppl 2002;43:s10-s18.
133. Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiat 1992;149(9):1183-1188.
134. Beiser M, Erickson D, Fleming JA, Iacono WG. Establishing the onset of psychotic illness. Am J Psychiat 1993;150(9):1349-1354.
135. Haas GL, Garratt LS, Sweeney JA. Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness. J Psychiat Res 1998;32(3-4):151-159.
136. Larsen TK, McGlashan TH, Moe LC. First-episode schizophrenia: I. early course parameters. Schizophrenia Bull 1996;22(2):241-256.
137. Hafner H, Riecher-Rossler A, An Der Heiden W, Maurer K, Fatkenheuer B, Loffler W. Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychol Med 1993;23(4):925-940.
138. Ho BC, Andreasen NC, Flaum M, Nopoulos P, Miller D. Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. Am J Psychiat 2000;157(5):808-815.
139. Browne S, Clarke M, Gervin M, Waddington JL, Larkin C, O'Callaghan E. Determinants of quality of life at first presentation with schizophrenia. Brit J Psychiat 2000;176:173-176.
140. Norman R, Malla AK. Duration of untreated psychosis: a critical examination of the concept and its importance. Psychol Med 2001;31(3):381-400.
141. Hambrecht M, Hafner H. Substance abuse and the onset of schizophrenia. Biol Psychiat 1996;40(11):1155-1163.
142. Sevy S, Robinson DG, Holloway S, et al. Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiat Scand 2001;104(5):367-374.
143. Rabinowitz J, Bromet EJ, Lavelle J, Carlson G, Kovasznay B, Schwartz JE. Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients. Psychol Med 1998;28(6):1411-1419.
144. Van Mastrigt S, Addington J, Addington D. Substance misuse at presentation to an early psychosis program. Soc Psych Psych Epid 2004;39(1):69-72.
145. Cantwell R, Brewin J, Glazebrook C, et al. Prevalence of substance misuse in first-episode psychosis. Brit J Psychiat 1999;174:150-153.
146. Hambrecht M, Hafner H. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective. Aust NZ J Psychiat 2000;34(3):468-475.
147. Ciompi L. Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophrenia Bull 1980;6(4):606-618.
148. McGlashan TH. The Chestnut Lodge follow-up study. II. long-term outcome of schizophrenia and the affective disorders. Arch Gen Psychiat 1984;41(6):586-601.
149. Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G. One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiat 1994;151(10):1409-1416.
150. McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ. EPPIC: an evolving system of early detection and optimal management. Schizophrenia Bull 1996;22(2):305-326.
151. Malla AK, Norman RM, Voruganti LP. Improving outcome in schizophrenia: the case for early intervention. Can Med Assoc J 1999;160(6):843-846.
152. Pelosi AJ, Birchwood M. Is early intervention for psychosis a waste of valuable resources? Brit J Psychiat 2003;182:196-198.
153. Spencer E, Birchwood M, McGovern D. Management of first-episode psychosis. Adv Psychiatr Treatment 2001;7:133-142.
154. Black K, Peters L, Rui Q, Milliken H, Whitehorn D, Kopala LC. Duration of untreated psychosis predicts treatment outcome in an early psychosis program. Schizophr Res 2001;47(2-3):215-222.
155. Larsen TK, Moe LC, Vibe-Hansen L, Johannessen JO. Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis. Schizophr Res 2000;45(1-2):1-9.
156. Wiersma D, Wanderling J, Dragomirecka E, et al. Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres. Psychol Med 2000;30(5):1155-1167.
157. Malla AK, Norman RM, Manchanda R, et al. One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophr Res 2002;54(3):231-242.
158. Malla A, Norman R, Manchanda R, Townsend L. Symptoms, cognition, treatment adherence and functional outcome in first-episode psychosis. Psychol Med 2002;32(6):1-11.
159. Scully PJ, Coakley G, Kinsella A, Waddington JL. Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia. Psychol Med 1997;27(6):1303-1310.
160. Craig TJ, Bromet EJ, Fennig S, Tanenberg-Karant M, Lavelle J, Galambos N. Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series? Am J Psychiat 2000;157(1):60-66.
161. Ho BC, Andreasen NC. Long delays in seeking treatment for schizophrenia. Lancet 2001;357(9260):898-900.
162. Linszen D, Lenior M, De Haan L, Dingemans P, Gersons B. Early intervention, untreated psychosis and the course of early schizophrenia. Brit J Psychiat Suppl 1998;172(33):84-89.
163. Verdoux H, Liraud F, Bergey C, Assens F, Abalan F, van Os J. Is the association between duration of untreated psychosis and outcome confounded? a two year follow-up study of first-admitted patients. Schizophr Res 2001;49(3):231-241.
164. Johannessen JO, McGlashan TH, Larsen TK, et al. Early detection strategies for untreated first-episode psychosis. Schizophr Res 2001;51(1):39-46.
165. Scholten DJ, Malla AK, Norman RM, et al. Removing barriers to treatment of first-episode psychotic disorders. Can J Psychiat 2003;48(8):561-565.
166. Melle I, Larsen TK, Haahr U, et al. Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch Gen Psychiat 2004;61(2):143-150.
167. Birchwood M, Todd P, Jackson C. Early intervention in psychosis: the critical period hypothesis. Brit J Psychiat Suppl 1998;172(33):53-59.
168. Harrison G, Hopper K, Craig T, et al. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Brit J Psychiat 2001;178:506-517.
169. Raphael B, Burrows GW, eds. Handbook of Studies on Preventative Psychiatry. Amsterdam, the Netherlands: Elsevier Science B.V.; 1995.
170. Malla AK, Norman RM. Early intervention in schizophrenia and related disorders: advantages and pitfalls. Curr Opin Psychiatr 2002;15(1):17-23.
171. Malla AM, Norman RM. Treating psychosis: is there more to early intervention than intervening early? Can J Psychiat 2001;46(7):645-648.
172. Wiersma D, Nienhuis FJ, Slooff CJ, Giel R. Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophrenia Bull 1998;24(1):75-85.
173. Thara R, Henrietta M, Joseph A, Rajkumar S, Eaton WW. Ten-year course of schizophrenia - the Madras longitudinal study. Acta Psychiat Scand 1994;90(5):329-336.
174. Lehtinen V, Aaltonen J, Koffert T, Rakkolainen V, Syvalahti E. Two-year outcome in first-episode psychosis treated according to an integrated model: is immediate neuroleptisation always needed? Eur Psychiat 2000;15(5):312-320.
175. Stirling J, White C, Lewis S, et al. Neurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort. Schizophr Res 2003;65(2-3):75-86.
176. Linszen D, Dingemans P, Lenior M. Early intervention and a five year follow up in young adults with a short duration of untreated psychosis: ethical implications. Schizophr Res 2001;51(1):55-61.
177. Tirupati NS, Rangaswamy T, Raman P. Duration of untreated psychosis and treatment outcome in schizophrenia patients untreated for many years. Aust NZ J Psychiat 2004;38(5):339-343.
178. Robinson DG, Woerner MG, McMeniman M, Mendelowitz A, Bilder RM. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiat 2004;161(3):473-479.
179. Susser E, Finnerty M, Mojtabai R, et al. Reliability of the Life Chart Schedule for assessment of the long-term course of schizophrenia. Schizophr Res 2000;42(1):67-77.
180. Addington J, Addington D. Impact of an early psychosis program on substance use. Psychiatr Rehabil J 2001;25(1):60-67.
181. Drake RE, McHugo GJ, Bebout RR, et al. A randomized clinical trial of supported employment for inner-city patients with severe mental disorders. Arch Gen Psychiat 1999;56(7):627-633.
182. Rosen A, Hadzi-Pavlovic D, Parker G. The Life Skills Profile: a measure assessing function and disability in schizophrenia. Schizophrenia Bull 1989;15(2):325-337.
183. Harrigan SM, McGorry PD, Krstev H. Does treatment delay in first-episode psychosis really matter? Psychol Med 2003;33(1):97-110.
184. Maziade M, Gingras N, Rodrigue C, et al. Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. I: nosology, sex and age of onset. Brit J Psychiat 1996;169(3):361-370.
185. Schmidt M, Blanz B, Dippe A, Koppe T, Lay B. Course of patients diagnosed as having schizophrenia during first episode occurring under age 18 years. Eur Arch Psy Clin N 1995;245(2):93-100.
186. Jarbin H, Ott Y, Von Knorring AL. Adult outcome of social function in adolescent-onset schizophrenia and affective psychosis. J Am Acad Child Psy 2003;42(2):176-183.
187. World Health Organization. WHO Psychiatric Disability Assessment Schedule. Geneva: World Health Organization; 1988.
188. Jung E, Krumm B, Biehl H, Maurer K, Bauer-Schubart C. The Mannheim Scale for the Assessment of Social Disability. Weinheim, Germany: Belz; 1989.
189. Strauss JS, Carpenter WT, Jr. The prediction of outcome in schizophrenia. II. relationships between predictor and outcome variables: a report from the WHO International Pilot Study of Schizophrenia. Arch Gen Psychiat 1974;31:37-42.
190. Lehman AF. Measures of quality of life among persons with severe and persistent mental disorders. Soc Psych Psych Epid 1996;31(2):78-88.
191. Katschnig H. How useful is the concept of quality of life in psychiatry? In: Katschnig H, Freeman H, Sartorius N, eds. Quality of Life in Mental Disorders. New York: Wiley; 1997:3-15.
192. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. J Amer Med Assoc 1995;273(1):59-65.
193. Meltzer HY, Burnett S, Bastani B, Ramirez LF. Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Community Psych 1990;41(8):892-897.
194. Naber D. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharm 1995;10(suppl 3):133-138.
195. Awad AG, Voruganti LN. Intervention research in psychosis: issues related to the assessment of quality of life. Schizophrenia Bull 2000;26(3):557-564.
196. Angermeyer MC, Katschnig H. Theoretical models of quality of life for mental disorders. In: Katschnig H, Freeman H, Sartorius N, eds. Quality of Life in Mental Disorders. New York: Wiley; 1997:19-30.
197. Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. conceptual framework and item selection. Med Care 1992;30(6):473-483.
198. Norman RM, Malla AK, McLean T, et al. The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale. Acta Psychiat Scand 2000;102(4):303-309.
199. Dupuy H. The Psychological General Well-Being (PGWB) Index. In: Wenger NK, Mattson ME, Furberg CD, Elinson J, eds. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York: Le Jacq; 1984:170-183.
200. The World Health Organization Quality of Life Group. The World Health Organization Quality of Life assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 1998;46(12):1569-1585.
201. Becker M, Diamond R, Sainfort F. A new patient focused index for measuring quality of life in persons with severe and persistent mental illness. Qual Life Res 1993;2(4):239-251.
202. Heinrichs DW, Hanlon TE, Carpenter WT, Jr. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bull 1984;10(3):388-398.
203. Lehman AF. A quality of life interview for the chronically mentally ill. Eval Program Plann 1988;11(1):51-62.
204. Sim K, Mahendran R, Siris SG, Heckers S, Chong SA. Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression. Psychiat Res 2004;129(2):141-147.
205. Doyle M, Flanagan S, Browne S, et al. Subjective and external assessments of quality of life in schizophrenia: relationship to insight. Acta Psychiat Scand 1999;99(6):466-472.
206. Malla AK, Norman RM, McLean TS, et al. Determinants of quality of life in first-episode psychosis. Acta Psychiat Scand 2004;109(1):46-54.
207. Malla AK, Norman RM, McLean TS, McIntosh E. Impact of phase-specific treatment of first episode of psychosis on Wisconsin Quality of Life Index (Client version). Acta Psychiat Scand 2001;103(5):355-361.
208. Priebe S, Roeder-Wanner UU, Kaiser W. Quality of life in first-admitted schizophrenia patients: a follow-up study. Psychol Med 2000;30(1):225-230.
209. Priebe S, Gruyters T, Heinze M, Hoffmann C, Jakel A. [Subjective evaluation criteria in psychiatric care - methods of assessment for research and general practice]. Psychiat Prax 1995;22(4):140-144.
210. Oliver JP, Huxley PJ, Priebe S, Kaiser W. Measuring the quality of life of severely mentally ill people using the Lancashire Quality of Life Profile. Soc Psych Psych Epid 1997;32(2):76-83.
211. Herman DB, Susser ES, Jandorf L, Lavelle J, Bromet EJ. Homelessness among individuals with psychotic disorders hospitalized for the first time: findings from the Suffolk County Mental Health Project. Am J Psychiat 1998;155(1):109-113.
212. Whitty P, Browne S, Clarke M, et al. Systematic comparison of subjective and objective measures of quality of life at 4-year follow-up subsequent to a first episode of psychosis. J Nerv Ment Dis 2004;192(12):805-809.
213. Norman R, Malla A, McLean T, et al. The relationship of symptoms and level of functioning in schizophrenia to general well-being and the Quality of Life Scale. Acta Psychiat Scand 2000;102:303-309.
214. Nordentoft M, Jeppesen P, Petersen L, et al. Duration of untreated psychosis: results from the OPUS trial. Schizophr Res 2004;70(suppl 1):31.
215. Craig TK, Garety P, Power P, et al. The Lambeth Early Onset (LEO) team: randomised controlled trial of the effectiveness of specialised care for early psychosis. Brit Med J 2004;329(7474):1067.
216. Kuipers E, Holloway F, Rabe-Hesketh S, Tennakoon L. An RCT of early intervention in psychosis: Croydon Outreach and Assertive Support Team (COAST). Soc Psych Psych Epid 2004;39(5):358-363.
217. Malla AK, Norman R, Scholten D, Manchanda RA, McLean T. Community intervention for early identification of first episode psychosis: impact on DUP and patient characteristics. Soc Psych Psych Epid 2005;40:337-344.
218. Krstev H, Carbone S, Harrigan S, Curry C, Elkins K, McGorry P. Early intervention in first-episode psychosis: the impact of a community development campaign. Soc Psych Psych Epid 2004;39:711-719.